Acetyl-l-carnitine safety at a glance Use caution Generally well tolerated short-term, but long-term safety is not fully established
The FDAs message is narrower but sharper: it intends to take action against non-FDA-approved compounded GLP-1s that are mass-marketed as alternatives, and it warned that violations can lead to seizure or an injunction
While GLP-1 treatments like semaglutide and tirzepatide are a key part of the program, the support system surrounding them is what makes this program truly stand out
Emergency Protocols : Established procedures for managing serious adverse reactions, including immediate access to medical care
Similarly, insurers like Health New England are ending coverage for GLP1 weightloss drugs (Saxenda, Wegovy, Zepbound) for most commercial members as of January 1, 2026, unless their employer buys an optional rider
Pharmacological inhibition of drug transporters in breast cancer cells did not affect the ability of GSH to rescue tumour growth in cystine-free conditions (Extended Data Fig